John Edward Robinson

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Edward Robinson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cogent Biosciences, Inc. Chief Scientific Officer Common Stock 140,002 $5,423,677 $38.74 26 Dec 2025 Direct
Cogent Biosciences, Inc. Chief Scientific Officer Stock Option (Right to Buy) 65,000 17 Dec 2025 Direct

Insider Reports Filed by John Edward Robinson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
COGT Cogent Biosciences, Inc. 26 Dec 2025 1 -$3,486,600 4 Chief Scientific Officer 30 Dec 2025, 16:01
COGT Cogent Biosciences, Inc. 17 Dec 2025 4 -$5,522,921 4 Chief Scientific Officer 19 Dec 2025, 16:01
COGT Cogent Biosciences, Inc. 23 Jan 2025 1 $0 4 Chief Scientific Officer 27 Jan 2025, 16:58
COGT Cogent Biosciences, Inc. 23 Jan 2024 1 $0 4 Chief Scientific Officer 25 Jan 2024, 16:36
COGT Cogent Biosciences, Inc. 13 Feb 2023 1 $0 4 Chief Scientific Officer 15 Feb 2023, 14:52
COGT Cogent Biosciences, Inc. 25 Jan 2022 1 +$1,235,800 4 Chief Scientific Officer 27 Jan 2022, 16:40